Pre-Clinical Trial Application (CTA) Consultation Meeting

The pre-CTA consultation meeting provides an opportunity for the sponsor to present relevant data, discuss concerns and resolve issues regarding drug development. It also gives Health Canada an opportunity to provide guidance on the acceptability of the proposed trial(s).

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:29 (UTC)
Created April 17, 2026, 17:29 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-18 00:00:00
open_canada_keywords {"fr": ["demande d'essai préclinique", "réunion de consultation CTA", "promoteurs d'essais cliniques", "demandes d'essais cliniques"], "en": ["pre-clinical trial application", "CTA consultation meeting", "clinical-trial sponsors", "clinical-trial applications"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Réunion de consultation préalable au dépôt d'une Demande d'essais clinique
update_frequency as_needed